We also showed by screening colorectal tumor samples that this rearrangement is present with approximately 1% frequency in CRC and that IHC with anti TRKA antibodies can be successfully applied to facilitate the initial screening of rearranged tumors [4]. The gene discussed is NTRK1; the disease is colorectal carcinoma.